Sonoma Pharmaceuticals, Inc. — Director's Dealing 2012

Nov 9, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Oculus Innovative Sciences, Inc. (OCLS)
CIK: 0001367083
Period of Report: 2012-11-09

Reporting Person: Schutz James J (Director, Chief Operating Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-11-09	Common Stock	P	100	$.80	Acquired	53600	Direct
2012-11-09	Common Stock	P	11400	$.80	Acquired	65000	Direct
2012-11-09	Common Stock	P	500	$.80	Acquired	65500	Direct
2012-11-09	Common Stock	P	1000	$.78	Acquired	66500	Direct

Footnotes

F1: Mr. Schutz purchased these shares in the open market.